Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent

Environmental Pollution

Volumn 121, Issue 2, 2003, Pages 199-205

  Huggett, D B ^a,c   Khan, I A ^b   Foran, C M ^a   Schlenk, D ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c PFIZER INC   (United States)

Author keywords

Blockers; Effluent; Pharmaceuticals; Wastewater

Indexed keywords

DRUG PRODUCTS; EFFLUENT TREATMENT; MEDICAL APPLICATIONS;

TIME COURSE STUDIES;

WASTEWATER TREATMENT;

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; NADOLOL; PROPRANOLOL;

EFFLUENT; PHARMACEUTICAL INDUSTRY; WASTEWATER;

ARTICLE; EFFLUENT; UNITED STATES; WASTE WATER MANAGEMENT; WATER ANALYSIS; WATER SAMPLING; WATER TREATMENT;

ADRENERGIC BETA-ANTAGONISTS; METOPROLOL; MISSISSIPPI; NADOLOL; NEW YORK; PROPRANOLOL; TEXAS; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

UNITED STATES;

EID: 0037290268     PISSN: 02697491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0269-7491(02)00226-9     Document Type: Article

References (16)

1. Belfroid A., Van der Horst A., Vethaak A., Schafer A., Rijis G., Wegener J., Cofino W. Analysis and occurrence of estrogenic hormaones and their conjugates in surface water and waste water in the Netherlands. Science and the Total Environment. 225:1999;101-108.
2. Daughton C., Ternes T. Pharmaceuticals and personal care products in the environment. agents of subtle change? Environmental Health Perspectives. 107:1999;907-938.
3. Desbrow, C., Routledge, E., Sheehan, D., Waldock, M., Sumpter, J., 1996. The identification and assessment of estrogenic substances in sewage treatment works effluents. Environmental Agency, P2-i490/7.
4. Gamprel A., Wilkinson M., Boutilier R. β-adrenreceptor in the trout heart. characterization, quantification and effects of repeated catecholamine exposure General and Comparative. Endocrinology. 95:1994;259-272.
5. Insel P. Beta-Adrenergic receptors in pathophysiologic states and in clinical medicine. Perkins J. The β-Adrenergic Receptors. 1991;Humana Press, Clifton, NJ.
6. Lilius H., Hastbacka T., Isoma B. A comparison of the toxicity of 30 reference chemicals to Daphnia magna and Daphnia pulex. Environ. Toxicol. Chem. 14:1995;2085-2088.
7. Lho D., Hong J., Paek H., Lee J., Park J. Determination of phenolalkylamines, narcotic analgesics and Beta-blockers by gas chromatography/mass spectrophotometry. Journal of Analytical Toxicology. 14:1990;77-83.
8. McAnish J., Holmes B. Pharmacokinetic studies with atenolol in the dog. Biopharmaceutics and Drug Disposition. 4:1983;249-261.
9. McDevitt D. Comparison of pharmacokinetic properties of beta-adrenergic blocking drugs. European Heart Journal. 8:1987;9-14.
10. RXList Monographs, 2000. Online (RxList.com).
11. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Research. 32:1998;3245-3260.
12. 2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresenius Journal of Analytical Chemistry. 363:1998;329-340.
13. Ternes T., Stumpf M., Meuller J., Wilken R., Servos M. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Science and the Total Environment. 225:1999;81-90.
14. Tetans G., Lykkeboe G., Christensen N. Potency of adrenaline and noradrenaline for β adrenergic proton extrusion from red blood cells of rainbow trout. Journal of Experimental Biology. 134:1988;267-280.
15. Tomcikova O., Bezek S., Durisova M., Faberova V., Zemanek M., Trnovec T. Biliary excretion and enterohepatic circulation of two beta-adrenergic blocking drugs, exprolol and propranolol, in rats. Biopharmaceutics and Drug Disposition. 5:1984;153-162.
16. Wood C., Shelton G. Cardiovascular dynamics and adrenergic responses of the rainbow trout in vivo. Journal of Experimental Biology. 87:1980;247-270.